Epilepsy primary prevention

Revision as of 16:29, 12 December 2018 by Fahimeh Shojaei (talk | contribs)
Jump to navigation Jump to search

Epilepsy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epilepsy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

EEG

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epilepsy primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epilepsy primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epilepsy primary prevention

CDC on Epilepsy primary prevention

Epilepsy primary prevention in the news

Blogs on Epilepsy primary prevention

Directions to Hospitals Treating Epilepsy

Risk calculators and risk factors for Epilepsy primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

overview

Effective measures for the primary prevention of epilepsy include: Reducing the chance of possible epilepsy causes to happen ( Head trauma, Hypoglycemia, Cerebral palsy, Electrolyte disturbances, fever, drug abuse and Vitamin deficiency) and reduce the seizure triggers ( sleep deprivation, fever, light flashing, hyperventilation, alcohol, physical stress such as physical exercise or illness, psychological stress and depression).

Primary Prevention

References

  1. Annegers JF, Coan SP (October 2000). "The risks of epilepsy after traumatic brain injury". Seizure. 9 (7): 453–7. doi:10.1053/seiz.2000.0458. PMID 11034867.
  2. Dafoulas GE, Toulis KA, Mccorry D, Kumarendran B, Thomas GN, Willis BH, Gokhale K, Gkoutos G, Narendran P, Nirantharakumar K (February 2017). "Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study". Diabetologia. 60 (2): 258–261. doi:10.1007/s00125-016-4142-x. PMID 27796422.
  3. Diaconu G, Burlea M, Grigore I, Frasin M (2003). "[Epilepsy in different types of cerebral palsy]". Rev Med Chir Soc Med Nat Iasi (in Romanian). 107 (1): 136–9. PMID 14755984.
  4. Riggs JE (February 2002). "Neurologic manifestations of electrolyte disturbances". Neurol Clin. 20 (1): 227–39, vii. PMID 11754308.
  5. Shinnar S, Glauser TA (January 2002). "Febrile seizures". J. Child Neurol. 17 Suppl 1: S44–52. doi:10.1177/08830738020170010601. PMID 11918463.
  6. Cendes F, Andermann F, Carpenter S, Zatorre RJ, Cashman NR (January 1995). "Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans". Ann. Neurol. 37 (1): 123–6. doi:10.1002/ana.410370125. PMID 7818246.
  7. Keyser A, De Bruijn SF (1991). "Epileptic manifestations and vitamin B1 deficiency". Eur. Neurol. 31 (3): 121–5. doi:10.1159/000116660. PMID 2044623.
  8. Løyning Y (August 1993). "[Seizures and traffic risks]". Tidsskr. Nor. Laegeforen. (in Norwegian). 113 (18): 2231. PMID 8362382.
  9. Thapar A, Kerr M, Harold G (January 2009). "Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures". Epilepsy Behav. 14 (1): 134–40. doi:10.1016/j.yebeh.2008.09.004. PMID 18824131.
  10. LEVIN M (February 1950). "The pathogenesis of narcoleptic and epileptic seizures occurring under acute emotional stress". J. Nerv. Ment. Dis. 111 (2): 101–8. PMID 15409992.

Template:WH Template:WS